AG
SNNA

Artal Group’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Artal Group’s Portfolio SNNA Stock Details SNNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-99,000
Closed -$1.5M – 110
2018
Q2 		$1.5M Buy
+99,000
New +$1.5M 0.03% 73